Search research articles
Contact Us
Filters
Showing results (111-120 of 160) with videos related to
Page
of 16
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 20, 2023
[<sup>11</sup>C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier
Severin Mairinger, Sarah Leterrier, Thomas Filip, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 26, 2012
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier
Thomas Wanek, Claudia Kuntner, Jens P Bankstahl, et al.
Clinical Pharmacokinetics
|
December 15, 2010
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil
Claudia C Wagner, Marie Simpson, Markus Zeitlinger, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
February 12, 2015
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study
Martin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
EJNMMI Physics
|
November 3, 2024
Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study
Zacharias Chalampalakis, Markus Ortner, Masar Almuttairi, et al.
International Journal of Molecular Sciences
|
June 24, 2022
Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice
Michael Wölfl-Duchek, Severin Mairinger, Irene Hernández-Lozano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 10, 2023
Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Molecular Pharmaceutics
|
January 30, 2019
Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [<sup>11</sup>C]erlotinib
Alexander Traxl, Severin Mairinger, Thomas Filip, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 12, 2013
Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal positron emission tomography and in vitro study
Jens P Bankstahl, Marion Bankstahl, Kerstin Römermann, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2023
Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs
Irene Hernández-Lozano, Severin Mairinger, Thomas Filip, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 160) with videos related to
Sort By:
Page
of 16
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 20, 2023
[<sup>11</sup>C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier
Severin Mairinger, Sarah Leterrier, Thomas Filip, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 26, 2012
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier
Thomas Wanek, Claudia Kuntner, Jens P Bankstahl, et al.
Clinical Pharmacokinetics
|
December 15, 2010
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil
Claudia C Wagner, Marie Simpson, Markus Zeitlinger, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
February 12, 2015
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study
Martin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
EJNMMI Physics
|
November 3, 2024
Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study
Zacharias Chalampalakis, Markus Ortner, Masar Almuttairi, et al.
International Journal of Molecular Sciences
|
June 24, 2022
Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice
Michael Wölfl-Duchek, Severin Mairinger, Irene Hernández-Lozano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 10, 2023
Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Molecular Pharmaceutics
|
January 30, 2019
Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [<sup>11</sup>C]erlotinib
Alexander Traxl, Severin Mairinger, Thomas Filip, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 12, 2013
Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal positron emission tomography and in vitro study
Jens P Bankstahl, Marion Bankstahl, Kerstin Römermann, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2023
Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs
Irene Hernández-Lozano, Severin Mairinger, Thomas Filip, et al.
Page
of 16